Tamoxifen Citrate was first introduced by Astrazeneca Pharmaceuticals Lp in its drug Nolvadex on Approved Prior to Jan 1, 1982. Another drug containing Tamoxifen Citrate is Soltamox. 14 different companies have introduced drugs containing Tamoxifen Citrate.
Tamoxifen Citrate Patents
Given below is the list of patents protecting Tamoxifen Citrate, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Tamoxifen Citrate Generic API Manufacturers
Several generic applications have been filed for Tamoxifen Citrate. The first generic version for Tamoxifen Citrate was by Actavis Laboratories Fl Inc and was approved on Feb 20, 2003. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Aug 14, 2020.
Given below is the list of companies who have filed for
Tamoxifen Citrate generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Actavis Labs Fl Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 20MG BASE
tablet
Discontinued
ORAL
N/A
Feb 20, 2003
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
Feb 20, 2003
2. AEGIS PHARMS
Aegis Pharmaceuticals Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Aegis Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
Mar 31, 2003
EQ 20MG BASE
tablet
Discontinued
ORAL
N/A
Mar 31, 2003
3. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Apotex.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 20MG BASE
tablet
Prescription
ORAL
AB
Sep 23, 2011
EQ 10MG BASE
tablet
Prescription
ORAL
AB
Sep 23, 2011
Manufacturing Plant Locations
New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country
City
Firm Name
United States
Weston
Apotex Corp.
Canada
Brantford
Apotex Pharmachem Inc.
Winnipeg
Apotex Fermentation Inc.
Etobicoke
Apotex, Inc.
North York
Apotex Inc.
Richmond Hill
Apotex Inc.
Toronto
Apotex Inc.
India
Bangalore
Apotex Research Private Limited - Bioequivalence Centre
Bengaluru
Apotex Research Private Limited
Bangalore
Apotex Pharmachem India Pvt Ltd.
4. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Dr Reddys Labs Sa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE
tablet
Prescription
ORAL
AB
Feb 20, 2003
EQ 20MG BASE
(reference standard)
tablet
Prescription
ORAL
AB
Feb 20, 2003
5. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Eugia Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 20MG BASE
tablet
Prescription
ORAL
AB
Aug 14, 2020
EQ 10MG BASE
tablet
Prescription
ORAL
AB
Aug 14, 2020
Manufacturing Plant Locations
New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
Country
City
Firm Name
India
Pashamylaram
Eugia Pharma Specialities Limited
Medchal-Malkajgiri District
EUGIA Pharma Specialities Limited
Riico Industrial Area
EUGIA Pharma Specialities Limited
6. IVAX SUB TEVA PHARMS
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Ivax Sub Teva Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
Feb 20, 2003
EQ 20MG BASE
tablet
Discontinued
ORAL
N/A
Feb 20, 2003
7. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Mylan.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 20MG BASE
tablet
Prescription
ORAL
AB
Feb 20, 2003
EQ 10MG BASE
tablet
Prescription
ORAL
AB
Feb 20, 2003
Manufacturing Plant Locations
New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
Country
City
Firm Name
United States
San Carlos
Mylan Pharmaceuticals Inc.
Rockford
Mylan Institutional, Inc.
Santa Barbara
Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
Morgantown
Mylan Specialty, L.P.
Greensboro
Mylan Pharmaceuticals Inc
Saint Albans
Mylan Technologies, Inc.
Morgantown
MYLAN CONSUMER HEALTHCARE Inc.
India
Sinnar
Mylan Laboratories Limited
Aurangabad
Mylan Laboratories Limited (FDF-2)
Hosur
Mylan Laboratories Limited
Bangalore
Mylan Laboratories Limited
Hyderabad
Mylan Laboratories Limited
Sarigam
Mylan Laboratories Limited
Pithampur, District Dhar
Mylan Laboratories Limited
Anekal Taluk, Bangalore
Mylan Laboratories Limited
Canada
Etobicoke
Mylan Pharmaceuticals ULC
Ireland
Inverin
Mylan Teoranta
8. PHARMACHEMIE
Pharmachemie Bv has filed for 1 generic for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Pharmachemie.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
Mar 31, 2003
Manufacturing Plant Locations
New
Pharmachemie's manufacturing plants are situated in 1 country - Netherlands. Given below are the details of these plant locations as well as the firm names of Pharmachemie as present at those locations.
Country
City
Firm Name
Netherlands
Haarlem
Pharmachemie B.V. dba Teva Pharmachemie
9. ROXANE
Roxane Laboratories Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Roxane.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
Feb 20, 2003
EQ 20MG BASE
tablet
Discontinued
ORAL
N/A
Feb 20, 2003
10. TEVA
Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Teva.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 20MG BASE
tablet
Discontinued
ORAL
N/A
Apr 28, 2003
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
Apr 28, 2003
Manufacturing Plant Locations
New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
Country
City
Firm Name
United States
Malvern
Teva Branded Pharmaceutical Products R&D, Inc.
Miami
Teva Branded Pharmaceutical Products R & D, Inc.
Horsham
Teva Branded Pharmaceutical Products R&D
Fort Dodge
TEVA Animal Health Inc
India
Gajraula, Amroha
Teva API India Private Ltd.
Bhind
Teva API India Ltd- Malanpur
Canada
Scarborough
Teva Canada Limited
Markham
Teva Canada Limited
Stouffville
Teva Canada Limited
Czech Republic
Opava
Teva Czech Industries s.r.o.
Ireland
Dundalk
Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona
TEVA Medical Ltd.
11. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 1 generic for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Teva Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 20MG BASE
tablet
Prescription
ORAL
AB
Feb 20, 2003
12. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the
details of the strengths of this generic introduced by
Zydus Pharms.
